Search Login Register
Lymphoproliferative Disorders
(Lymphoproliferative Disorder)
Summary
Description:
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
Also Known As:
Lymphoproliferative Disorder; X-Linked Lymphoproliferative Syndrome; X-Linked Lymphoproliferative Disorder; Disorder, Lymphoproliferative; Disorder, X-Linked Lymphoproliferative Show All >>
Networked: 3477
relevant articles (128 outcomes,
203 trials/studies)
for this Disease
Key Drugs and Agents for Lymphoproliferative Disorders
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
rituximab (Mabthera)
:
28 outcomes 15 studies in 166 results
:
FDA 3
-
Methotrexate (Mexate)
:
10 outcomes 3 studies in 89 results
:
FDA 8
Generic
-
purine
:
5 outcomes 1 study in 35 results
: IBA
-
Cyclophosphamide (Cytoxan)
:
4 outcomes 3 studies in 27 results
:
FDA 10
Generic
-
Etoposide (VP 16)
:
4 outcomes in 6 results
:
FDA 16
Generic
-
fludarabine
:
3 outcomes 5 studies in 49 results
: IBA
-
Monoclonal Antibodies
:
3 outcomes 4 studies in 36 results
: IBA
-
Cladribine
:
3 outcomes 3 studies in 32 results
:
FDA 3
Generic
-
alemtuzumab (Campath)
:
3 outcomes 2 studies in 25 results
:
FDA 2
-
Sirolimus (Rapamycin)
:
3 outcomes in 11 results
:
FDA 2
Show All >>
Diseases Related to Lymphoproliferative Disorders
-
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
-
Rheumatoid Arthritis
-
Infection
-
Lymphoma (Lymphomas)
-
Non-Hodgkin Lymphoma (Lymphosarcoma)
Show All >>
Key Therapies for Lymphoproliferative Disorders
Efficacy Chart >>
-
Transplants (Transplant)
:
28 outcomes 48 studies in 1141 results
-
Transplantation (Transplant Recipients)
:
15 outcomes 28 studies in 527 results
-
Drug Therapy (Chemotherapy)
:
13 outcomes 4 studies in 97 results
-
Organ Transplantation
:
5 outcomes 6 studies in 226 results
-
Kidney Transplantation
:
3 outcomes 7 studies in 95 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.